Sablixto Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 13 years ago on Monday, November 8, 2010, according to the United State Patent & Trademark Office
Word Mark Sablixto
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 77307015
Status Date Monday, November 8, 2010
Filing Date Monday, November 8, 2010
Attorney Tanya Fickenscher Leonard

Correspondent

Tanya Fickenscher Leonard
Bristol-Myers Squibb Company
Trademark Department
345 Park Avenue
New York NY 10154

Case File Statements

Goods & Services Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Translation of Words in Mark SABLIXTO has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, October 23, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.